4. Accounts Payable

As of December 31, 2013, Current Liabilities included accounts payable of $76,109 comprised primarily of $31,383 owed to the Company’s attorneys related to fund raising legal costs for work on a direct offering of the Company’s securities for sale to certain institutional investors, $8,343 owed to the Company’s lawyers for fund raising legal costs for work done on a shelf registration Bio-Path securities submitted to the United States Securities and Exchange Commission (SEC) and general corporate legal work, $13,102 owed to the Company’s drug substance manufacturer, $11,166 owed to the provider of business wire services, $6,880 owed for the firm that facilitates the Company’s filings with the SEC; and the balance of $5,235 owed to shareholder services providers and a raw material manufacturer. These amounts were subsequently paid in the first quarter of 2014. As of December 31, 2012, Current Liabilities included accounts payable $57,000 and accounts payable – related party of $8,582, which amounts were subsequently paid in 2013.